490 related articles for article (PubMed ID: 16169724)
1. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation.
Vijaya Bhaskar Reddy M; Tsai WJ; Qian K; Lee KH; Wu TS
Bioorg Med Chem; 2011 Dec; 19(24):7711-9. PubMed ID: 22055718
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
4. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
Huang WH; Lee AR; Chien PY; Chou TC
J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
11. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antileukemic and antiplatelet activities of 2,3-diaryl-6,7-dihydro-5H-1,4-diazepines.
Ramajayam R; Giridhar R; Yadav MR; Balaraman R; Djaballah H; Shum D; Radu C
Eur J Med Chem; 2008 Sep; 43(9):2004-10. PubMed ID: 18191304
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone.
Lee HS
Bioresour Technol; 2006 Aug; 97(12):1372-6. PubMed ID: 16112857
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro study of platelet antiaggregant activity of some 4-quinazolinone derivatives.
Gravier D; Dupin JP; Casadebaig F; Hou G; Boisseau M; Bernard H
Pharmazie; 1992 Feb; 47(2):91-4. PubMed ID: 1635928
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
Ferlin MG; Borgo C; Deana R
Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
[TBL] [Abstract][Full Text] [Related]
17. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.
Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
[TBL] [Abstract][Full Text] [Related]
19. New 2-amino-thiazole-4-acetamides with antiplatelet activity.
Rehse K; Baselt T
Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
